Matching-Adjusted Indirect Comparisons of Diroximel Fumarate, Ponesimod, and Teriflunomide for Relapsing Multiple Sclerosis

MS Treatments

Jahr

Publikationsjahr
2023

Autoren

Autorenliste der Publikation
Jiang T, Ziemssen T, Wray S, Shen C, Söderbärg K, Lewin JB, Božin I, Freedman MS.

Verlag

Publisher-Information
CNS Drugs. 2023 May 8. PMID: 37155132.

Link

Zur Publikation (externer Server)
https://doi.org/10.1007/s40263-023-01002-x

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
TreatmentsMSZ2023